PRNP and Parkinson disease: In Alzheimer’s or Parkinson’s diseases, dysregulation of PrPC function(s) upon binding of oligomers of Aβ peptides [2,7] or pathological fibrils of α-synuclein [8] to common PrPC epitopes provokes synaptic failure at the root of synaptic plasticity or long term potentiation alterations.